These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23035031)

  • 1. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.
    Lopresti AL; Hood SD; Drummond PD
    J Psychopharmacol; 2012 Dec; 26(12):1512-24. PubMed ID: 23035031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies.
    Lopresti AL
    J Psychopharmacol; 2017 Mar; 31(3):287-302. PubMed ID: 28135888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.
    Lopresti AL; Maes M; Maker GL; Hood SD; Drummond PD
    J Affect Disord; 2014; 167():368-75. PubMed ID: 25046624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin in antidepressant treatments: An overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges.
    Zhang Y; Li L; Zhang J
    Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):243-253. PubMed ID: 32544307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression.
    Tizabi Y; Hurley LL; Qualls Z; Akinfiresoye L
    Molecules; 2014 Dec; 19(12):20864-79. PubMed ID: 25514226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats.
    Gazal M; Valente MR; Acosta BA; Kaufmann FN; Braganhol E; Lencina CL; Stefanello FM; Ghisleni G; Kaster MP
    Eur J Pharmacol; 2014 Feb; 724():132-9. PubMed ID: 24384407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin: therapeutical potential in ophthalmology.
    Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
    Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Role of Curcumin for the Treatment of Major Depressive Disorder.
    Lopresti AL
    CNS Drugs; 2022 Feb; 36(2):123-141. PubMed ID: 35129813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair.
    Kulkarni SK; Akula KK; Deshpande J
    Pharmacology; 2012; 89(1-2):83-90. PubMed ID: 22343362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB.
    Wang R; Li YB; Li YH; Xu Y; Wu HL; Li XJ
    Brain Res; 2008 May; 1210():84-91. PubMed ID: 18420184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of curcumin on depressive-like behaviors in mice.
    Xu Y; Ku BS; Yao HY; Lin YH; Ma X; Zhang YH; Li XJ
    Eur J Pharmacol; 2005 Jul; 518(1):40-6. PubMed ID: 15987635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin and neurodegenerative diseases: a perspective.
    Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice.
    Zhang L; Xu T; Wang S; Yu L; Liu D; Zhan R; Yu SY
    Behav Brain Res; 2012 Nov; 235(1):67-72. PubMed ID: 22820234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.
    He X; Zhu Y; Wang M; Jing G; Zhu R; Wang S
    Int J Nanomedicine; 2016; 11():4975-4990. PubMed ID: 27757031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test.
    Zhang L; Xu T; Wang S; Yu L; Liu D; Zhan R; Yu SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():12-7. PubMed ID: 22960607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant effects of curcumin in spinal cord injury in rats.
    Sahin Kavaklı H; Koca C; Alıcı O
    Ulus Travma Acil Cerrahi Derg; 2011 Jan; 17(1):14-8. PubMed ID: 21341128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats.
    Xu Y; Ku BS; Yao HY; Lin YH; Ma X; Zhang YH; Li XJ
    Pharmacol Biochem Behav; 2005 Sep; 82(1):200-6. PubMed ID: 16171853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural polyphenols in the management of major depression.
    Pathak L; Agrawal Y; Dhir A
    Expert Opin Investig Drugs; 2013 Jul; 22(7):863-80. PubMed ID: 23642183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.